Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ABBOTT LABORATORIES Director's Dealing 2008

Feb 13, 2008

29777_dirs_2008-02-12_0e3209bb-f65d-40a0-ac89-752d87e7b9a3.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ABBOTT LABORATORIES (ABT)
CIK: 0000001800
Period of Report: 2008-02-08

Reporting Person: ROBERTS ROY S (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2008-02-08 Common shares without par value M 5010 $35.9192 Acquired 22248 Direct
2008-02-08 Common shares without par value M 4417 $33.9503 Acquired 26665 Direct
2008-02-08 Common shares without par value S 3827 $56.731 Disposed 22838 Direct
2008-02-08 Common shares without par value S 5600 $56.732 Disposed 17238 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2008-02-08 Option (right to buy) $35.9192 M 5010 Disposed 2010-04-27 Common shares (5010) Direct
2008-02-08 Option (right to buy) $33.9503 M 4417 Disposed 2008-04-23 Common shares (4417) Direct

Footnotes

F1: Stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3.